Loading chat...

NY A10668

Bill

Status

Introduced

7/22/2024

Primary Sponsor

Philip Ramos

Click for details

Origin

Assembly

2023-2024 General Assembly

AI Summary

  • Requires pharmacists to obtain express written consent from patients before substituting a prescribed drug product for a less expensive generic or alternative drug product with the same active ingredients, dosage form, and strength.

  • Applies the express written consent requirement to out-of-state dispensers when patients choose to have prescriptions filled outside New York.

  • Extends the consent requirement to biological product substitutions, requiring patients to authorize pharmacists to substitute prescribed biological products for less expensive interchangeable biological products.

  • Takes effect ninety days after the bill becomes law, with regulatory agencies authorized to implement necessary rules immediately upon enactment.

Legislative Description

Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.

Last Action

referred to higher education

7/22/2024

Committee Referrals

Higher Education7/22/2024

Full Bill Text

No bill text available